159 related articles for article (PubMed ID: 6944265)
1. Treosulphan.
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():341-7. PubMed ID: 6944265
[No Abstract] [Full Text] [Related]
2. Mutagenicity of the human carcinogen treosulphan in Salmonella.
Zeiger E; Pagano DA
Environ Mol Mutagen; 1989; 13(4):343-6. PubMed ID: 2544419
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity of alkylating cytostatic drugs in animals.
Berger MR
IARC Sci Publ; 1986; (78):161-76. PubMed ID: 3583389
[No Abstract] [Full Text] [Related]
4. Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice.
Stoner GD; Shimkin MB; Kniazeff AJ; Weisburger JH; Weisburger EK; Gori GB
Cancer Res; 1973 Dec; 33(12):3069-85. PubMed ID: 4202501
[No Abstract] [Full Text] [Related]
5. [The cancerogenicity of antineoplastic agents].
Rieche K
Arch Geschwulstforsch; 1969; 34(2):240-54. PubMed ID: 4920118
[No Abstract] [Full Text] [Related]
6. Results of tests for micronuclei and chromosomal aberrations in mouse bone marrow cells with the human carcinogens 4-aminobiphenyl, treosulphan, and melphalan.
Shelby MD; Gulati DK; Tice RR; Wojciechowski JP
Environ Mol Mutagen; 1989; 13(4):339-42. PubMed ID: 2737185
[TBL] [Abstract][Full Text] [Related]
7. [Experimental studies on the carcinogenic effects of anticancer chemotherapeutics and immunosuppressive agents].
Schmähl D; Osswald H
Arzneimittelforschung; 1970 Oct; 20(10):1461-7. PubMed ID: 5536412
[No Abstract] [Full Text] [Related]
8. Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.
Wheeler GP; Bowdon BJ; Grimsley JA; Lloyd HH
Cancer Res; 1974 Jan; 34(1):194-200. PubMed ID: 4809457
[No Abstract] [Full Text] [Related]
9. Carcinogenicity of alkylating cytostatic drugs: conclusions and directions for future research.
Kaldor J; Schmähl D
IARC Sci Publ; 1986; (78):321-3. PubMed ID: 3583396
[No Abstract] [Full Text] [Related]
10. Tumor inductions by cytostatics in man.
Hunstein W
Recent Results Cancer Res; 1975; (52):50-6. PubMed ID: 796914
[No Abstract] [Full Text] [Related]
11. Covalent modification of DNA by antineoplastic agents.
Hemminki K; Ludlum DB
J Natl Cancer Inst; 1984 Nov; 73(5):1021-8. PubMed ID: 6387240
[No Abstract] [Full Text] [Related]
12. [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
Schmähl D
Internist (Berl); 1971; 12():Suppl 1:115-9. PubMed ID: 5002614
[No Abstract] [Full Text] [Related]
13. Vincristine sulphate.
IARC Monogr Eval Carcinog Risk Chem Hum; 1981 May; 26():365-84. PubMed ID: 6944267
[No Abstract] [Full Text] [Related]
14. [Novel Bis-sulfonic Acid Esters with Cytostatic Activity (author's transl)].
Senning A; Buchholt HC; Bierling R
Arzneimittelforschung; 1976; 26(10):1800-9. PubMed ID: 191037
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent cytotoxic and mutagenic effects of antineoplastic alkylating agents on human lymphoblastoid cells.
Sanderson BJ; Johnson KJ; Henner WD
Environ Mol Mutagen; 1991; 17(4):238-43. PubMed ID: 2050131
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of the human carcinogen treosulphan, and its hydrolysis product, dl-1,2:3,4-diepoxybutane in mammalian cells.
Zhu S; Zeiger E
Environ Mol Mutagen; 1993; 21(1):95-9. PubMed ID: 8419160
[TBL] [Abstract][Full Text] [Related]
17. Treosulphan, myleran and butadiene: similarities and differences.
Ashby J
Mutat Res; 1993 Jul; 300(2):77-8. PubMed ID: 7685496
[No Abstract] [Full Text] [Related]
18. [The effects of carcinogens and mutagens on the nucleic acids. II. Peculiarities of the interaction of DNA with some bifunctional alkylating agents].
Kushner VP; Khodosova IA
Tsitologiia; 1966; 8(4):534-9. PubMed ID: 5976183
[No Abstract] [Full Text] [Related]
19. Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications.
Beelen DW; Trenschel R; Casper J; Freund M; Hilger RA; Scheulen ME; Basara N; Fauser AA; Hertenstein B; Mylius HA; Baumgart J; Pichlmeier U; Hahn JR; Holler E
Bone Marrow Transplant; 2005 Feb; 35(3):233-41. PubMed ID: 15592494
[TBL] [Abstract][Full Text] [Related]
20. Busulfan-induced apoptosis in rat placenta.
Furukawa S; Usuda K; Abe M; Hayashi S; Ogawa I
Exp Toxicol Pathol; 2007 Oct; 59(2):97-103. PubMed ID: 17716881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
